Clinical Trial Update: A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy for the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's Disease

View source ↗

Summary

This document describes a post-approval registry for Exablate 4000 Type 1.0/1.1 unilateral thalamotomy, evaluating its use for tremor in tremor-dominant Parkins…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: InSightec | Conditions: Tremor Associated With Tremor Dominant Parkinson's Disease | Status: RECRUITING